Introduction {#s1}
============

The regulation of eukaryotic gene expression is complex and rigorous, and influenced by various levels, such as the genetic level of DNA regulation, epigenetic level of chromatin regulation, the post-transcription level of RNA regulation, the translation and protein processing regulation, phosphorylation and acetylation of protein, heat shock protein regulation, etc. ([@B1]--[@B4]). For a given gene, intergenic regions play an important role in the regulation ([@B5]--[@B7]). The eukaryotic promoter, a region with various regulatory elements, is located upstream of the gene and determines the level of expression via different regulatory factors ([@B8], [@B9]).

Methylation of genomic DNA, as a major epigenetic modification, generally modulates transcription by influencing the binding of regulatory factors to regulatory elements ([@B10]). In vertebrates, DNA methylation is throughout the genome and involved in silencing of gene expression during cellular differentiation and development ([@B11]--[@B15]). CpG island is the major target for methylation and plays a vital role in inhibiting gene expression ([@B16]). Dynamic methylation pattern of CpG island in a core promoter is involved in the regulation of gene expression ([@B17]). In insects, DNA methylation is restricted to the transcribed regions and primarily involved in behavioral plasticity and social behavior ([@B17]--[@B22]). Unlike mammals and insects, studies on DNA methylation are relatively rare in crustaceans and have so far been reported only in the water flea, *Daphnia magna* and *Daphnia pulex*. In *D. magna*, DNA methylation levels can be affected by Zn exposure and entailed at different histories ([@B23], [@B24]). In *D. pulex*, the 5-methyl-cytosine (5-mC) and 5-hydroxymethyl-cytosine (5-hmC) can inhibit the expression of the cullin-associated NEDD8-dissociated 2 (*Cand2*) gene, cytochrome C oxidase subunit IV (*Cox4*) gene, and juvenile hormone epoxide hydrolase 1 (*Ephx1*) gene ([@B25]).

Crustacean female sex hormone (CFSH), a key regulator of sex differentiation, has been shown to regulate reproductive processes such as the development of sexually dimorphic traits and expression of androgenic gland hormone (IAG) ([@B26]--[@B28]). The ontogenic of *CFSH* expression was detected in embryos at hatching stage in the blue crab, *Callinectes sapidus* ([@B26]). In the mud crab, *Scylla paramamosain, Sp-CFSH* expression shows tissue-specific and gender-variant pattern, which was exclusively expressed in the eyestalk ganglion and higher in mature females than in males ([@B27]). In addition, *Sp-CFSH* expression was dynamic during the development of the androgenic gland (AG) in *S. paramamosain*, which was maintained at high levels at the early stage (stages I and II) and then reduced significantly at the mature stage (stage III) ([@B27]).

To explore the regulatory mechanism of expression, the 5′-flanking region of *Sp-CFSH* was cloned and analyzed. Sodium bisulfite sequencing and methylated DNA immunoprecipitation were used to investigate the involvement of DNA methylation in the regulation of *Sp-CFSH* expression. Moreover, CpG dinucleotide site methylation and activity of the site-directed mutation (SDM) reporter vector were analyzed to demonstrate the regulatory mechanism that methylation inhibits *Sp-CFSH* expression.

Materials and Methods {#s2}
=====================

Animal Sources
--------------

Mud crabs (*S. paramamosain*) were obtained in March from a local market in Xiamen, Fujian Province, China. They were reared in tanks (temperature: 27 ± 2°C; salinity: 26 ± 1 ppm) for a week and fed with the meat of the white Pacific shrimp, *Litopenaeus vannamei*. The female crabs (carapace width 4.9--12.5 cm, body weight 115--382 g) and male crabs at stage III of AG development (*n* = 3, carapace width 9.3--11.8 cm, body weight 230--372 g) ([@B27], [@B29]) were anesthetized; the muscle and eyestalk ganglion were dissected to prepare the genomic DNA. In addition, the eyestalk ganglion of female crabs (*n* = 8) were collected to analyze the *Sp-CFSH* expression. Ovarian development was distinguished according to the morphological characteristics and confirmed by histological observation ([@B30], [@B31]). All the animals used in this study have been approved by the Animal Ethics Committee of Xiamen University.

Cloning of the 5′-Flanking Sequence of *Sp-CFSH*
------------------------------------------------

The genomic DNA was purified from muscle using the Universal Genomic DNA Extraction kit (TaKaRa, Japan). Tail-PCR was employed to clone the 5′-flanking region of *Sp-CFSH* according to the manufacturer\'s instructions ([@B32], [@B33]). The gene-specific primers (SP1-SP3 and SP4-SP6) ([Table 1](#T1){ref-type="table"}) were designed based on the sequence of *Sp-CFSH* ([@B27]) and used to clone the 5′-flanking region with random primers (AP1-4) in the Genome Walking kit (TaKaRa, Dalian, China).

###### 

The primers used in the present study.

  **Name**       **Sequence (5^**′**^ → 3^**′**^)**          **Application**
  -------------- ------------------------------------------- --------------------------------------
  SP1            CATGTGTCCTATGATGGAGGAACG                    Tail-PCR
  SP2            GCAAGAAATGCTGGACACGTGAAG                    
  SP3            AGGGAAGTTCTGTTCTGCTTCAT                     
  SP4            GTAGTAAATCCCAGGTGCGTAAAG                    
  SP5            GACAACCTACTCAGTAACATCG                      
  SP6            GCGAGCGACAAGGCACAGTAAT                      
  *Sp-cfsh*-QF   cgg[GGTACC]{.ul}AATCGGCATTTAGGTTTATTTGGTC   Cloning the 5**′**-flanking sequence
  *Sp-cfsh*-QR   cgc[GGATCC]{.ul}TGTAAGCCTTAGGGAAGTTCTGTT    
  *Sp-cfsh*-F    CGTGTCCAGCATTTCTTGCAGTACC                   qRT-PCR
  *Sp-cfsh*-R    TCATGTGTCCTATGATGGAGGAACG                   
  *Sp-ak*-F      TTCCTCCACCCTGTCCAACC                        
  *Sp-ak*-R      GAAGCGGTCACCCTCCTTGA                        
  BSP-F          TTTTTAATTAAAATAAATATTTGATT                  Determination of DNA methylation
  BSP-R          ATAAAAATTTTAACATCCATCTCAC                   
  p*sp-cfsh*-F   cgg[GGTACC]{.ul}TATTTACATGAAGATGCAATGGGCT   SDM
  p*sp-cfsh*-R   ccc[AAGCTT]{.ul}CCTTAGGGAAGTTCTGTTCTGCTTC   
  m*sp-cfsh*-F   ACAAACACCTGACTCTACCGCGCTGGTT                
  m*sp-cfsh*-R   AACCAGCGCGGTAGAGTCAGGTGTTTGT                

Bioinformatics Analysis
-----------------------

NNPP (<http://www.fruitfly.org/seq_tools/promoter.html>) was used to predict the core promoter region and transcription initiation site with the minimum promoter score of 0.75.

AliBaba 2.1 (<http://gene-regulation.com/pub/programs/alibaba2/index.html>) with defaulted parameters was applied to predict the potential transcription factor binding sites.

MethPrimer (<http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi>) was applied to predict the CpG island, which is defined using the following criteria ([@B34]): island size with minimum length 200 bp, GC content \<55%, and ratio CpG observed/expected \< 0.60.

*Sp-CFSH* Promoter Activity Analysis
------------------------------------

The 5′-flanking sequence of *Sp-CFSH* was sequenced and cloned into pMD19-T vector (TaKaRa, Dalian, China). After digesting with KpnI and HindIII (TaKaRa, Dalian, China), the 5′-flanking sequence of *Sp-CFSH* was ligated to a promoterless enhanced green fluorescent protein (EGFP) report vector (pEGFP-1; YouBio, Changsha, China). The recombinant vector (pEGFP-pCFSH) was used to test promoter activity by transfecting HEK293FT cells. The HEK293FT cells were obtained from the China Center for Type Culture Collection, Wuhan. They were cultured in high-glucose DMEM (HyClone, USA) with 10% FBS (Gibco, USA), 1% 100 penicillin--streptomycin (Gibco, USA) and incubated at 37°C under 5% CO~2~. Cells were plated on 24-well plates overnight, and then transient transfections were performed using Lipofectamine^TM^ 2000 Reagent (Invitrogen, China) with 1 μg of pEGFP-pCFSH following the manufacturer\'s protocols. pEGFP-1 and pEGFP-N1 were used as the negative control and mock transfection, respectively. pEGFP-N1 was gifted by Dr. Kejian Wang of College of Ocean and Earth Sciences, Xiamen University, China.

*Sp-CFSH* Expression Analysis
-----------------------------

Total RNA was extracted from eyestalks using TRIzol Reagent (Invitrogen, USA), and the quality was detected using NanoDrop-2000 spectrophotometer (Thermo Fisher Scientific) according to the manufacturer\'s instructions. The cDNAs were synthesized using 1 μg of total RNA and TransScriptII One-step gDNA Removal and cDNA Synthesis SuperMix kit (TransGen, Beijing, China) according to the manufacturer\'s protocol. The cDNAs were diluted four times for qRT-PCR analysis. The qRT-PCR was performed with 7500 Fast Real-Time PCR (Applied Biosystems), with the reaction volumes of 10 μl of 2 × PCR Master Mix with SYBR Green, 2 μl of dilute cDNA, 0.8 μl of each primer (1 mM), 6.4 μl of water; the reaction was performed under the following conditions: 94°C for 10 min followed by 40 cycles of 94°C for 30 s, 58°C for 30 s, 72°C for 30 s, and a final extension at 72°C for 10 min. *Arginine kinase* (*AK*; GenBank accession number: [JQ031765](JQ031765)) was used as reference, and the primers used for qRT-PCR are listed in [Table 1](#T1){ref-type="table"}.

Determination of DNA Methylation Level Using Sodium Bisulfite Genomic Sequencing
--------------------------------------------------------------------------------

The bisulfite modification of genomic DNA was performed using ZYMO EZ DNA Methylation-Gold kit (D5005, Zymo Research, USA) according to the manufacturer\'s instructions. PCR was carried out with the bisulfate-specific primers ([Table 1](#T1){ref-type="table"}), and products were purified and cloned into the pMD19-T vector. After transfection, 10 positive clones were selected and sequenced. The analysis was performed as previously described ([@B17]).

The rate of promoter methylation was calculated by the formula I^Me^/10, where I^Me^ and 10 represent the number of the methylated promoters and sequenced promoters, respectively.

Average methylation of promoter was calculated by the formula $\sum\limits_{i = 1}^{N}{\text{Si/}12\text{/N}}$, where S~i~, 12, and N represent the number of the methylated dinucleotides site, 12 sites of CpG island, and methylated promoters, respectively.

Average methylation levels of the CpG dinucleotide site was figured by the formula S^Me^/10, where S^Me^ and 10 represent the number of methylated dinucleotides site and 10 dinucleotides site of sequenced promoters, respectively.

The results from at least three independent experiments were quantified and averaged.

Methylated DNA Immunoprecipitation (MeDIP)
------------------------------------------

MeDIP analysis was performed as previously described with minor modifications ([@B35]). The genomic DNA was sonicated (15 min on ice with 15 s on/off intervals; Branson Sonifier S-450D, USA) to yield DNA fragments from 200 to 500 bp in length. One microgram of fragmented DNA was heated and denatured to produce a single-stranded DNA, then immunoprecipitated with l μg of anti-5mC antibody (ab10805; Abcam, UK) or with 1 μg of normal mouse IgG (as negative control) at 4°C for 12 h. Pre-cleared Protein A/G PLUS-Agarose (sc-2003; Santa Cruz) immunoprecipitated antibody/DNA complexes were washed away unless specifically bound, and finally resuspended with 500 μl of digestive buffer containing proteinase K. The DNA fragments was purified with phenol chloroform extracting and ethanol precipitated, then resuspended in 50 μl of Tris buffer (10 mM Tris, pH 8.5). Finally, 2 μl of DNA fragments was used for analyzing the methylated rate of the 5′-flanking region by PCR.

Promoter Activity Analysis of the Binding Site of Sp1 With Site-Directed Mutagenesis (SDM)
------------------------------------------------------------------------------------------

SDM was achieved by overlap extension PCR reactions with primers containing the mutational bases and was used to identify the function of transcription elements. p*sp-cfsh*-F/m*sp-cfsh*-R and p*sp-cfsh*-R/m*sp-cfsh*-F ([Table 1](#T1){ref-type="table"}) were used to amplify p*sp-cfsh*-1 and p*sp-cfsh*-2 with procedure as follows: 94°C for 5 min; 34 cycles of 94°C for 30 s, 57°C for 30 s, 72°C for 1 min, followed by the final extension at 72°C for 10 min using the ABI 2720 Thermal Cycler (Applied Biosystems, USA). The second reaction was carried out with amplification system that contained 2.5 μl of 10 × Ex Taq Buffer (TaKaRa, Dalian, China), 2 μl of dNTP, 0.25 μl of Ex Taq, 1 μl of p*sp-cfsh*-1, 1 μl of p*sp-cfsh*-2, and 16.65 μl of water, under the conditions 94°C for 5 min; 10 cycles of 94°C for 40 s, 57°C for 1 min, 72°C for 1 min, followed by 20°C for 5 min; Then, 0.8 μl of p*sp-cfsh*-F and 0.8 μl of p*sp-cfsh*-R were added to the amplification system and reaction under the conditions 35 cycles of 94°C for 40 s, 57°C for 1 min, 72°C for 1 min, followed by 72°C for 10 min. The products were purified and digested with KpnI and HindIII (TaKaRa, Dalian, China), then inserted into pGL3-Basic vector. The reporter vectors were transiently transfected into HEK293FT cells, and the relative luciferase activity was evaluated by the Dual-Luciferase Reporter Assay System (Promage, USA). pRL-TK vector was co-transfected to normalize the transfection efficiency. The reporter vector with normal transcription element and pGL3-basic were employed as the control and the negative control, respectively.

Statistical Analysis
--------------------

The data are presented as means ± standard error of mean (SEM) of three or six independent experiments. The statistical evaluation was performed in the GraphPad Prism 6 software package (San Diego, CA, USA). Statistical analysis among groups was conducted with one-way ANOVA test, and a value of *p* \< 0.05 was considered statistically significant.

Results {#s3}
=======

Quantitative Analysis of *Sp-CFSH* Expression
---------------------------------------------

A previous study showed that the expression of *Sp-CFSH* was dynamic during the development of AG in males. It was high at the early stage (stages I and II) and significantly decreased at the mature stage (stage III). To examine the expression of *Sp-CFSH* during ovarian development, cDNA was derived and analyzed from the eyestalk ganglion at the pre-vitellogenic stage ([Figure S1A](#SM1){ref-type="supplementary-material"}), early-vitellogenic stage ([Figure S1B](#SM1){ref-type="supplementary-material"}) and late-vitellogenic stage ([Figure S1C](#SM1){ref-type="supplementary-material"}). The results showed that the expression of *Sp-CFSH* was significantly high at the pre-vitellogenic stage and late-vitellogenic stage compared with that of the early-vitellogenic stage ([Figure 1A](#F1){ref-type="fig"}). Females at the early-vitellogenic stage and males at the mature stage were chosen to compare the expression of *Sp-CFSH* in the two sexes, and the results showed that the expression of *Sp-CFSH* in females was significantly higher than that in males ([Figure 1B](#F1){ref-type="fig"}).

![Quantitative analysis of *Sp-CFSH* expression. **(A)** Expression of *Sp-CFSH* at different stages of ovarian development. **(B)** Expression of *Sp-CFSH* in two sexes. The eyestalk ganglion of females at pre-vitellogenic stage, early-vitellogenic stage, and late-vitellogenic stage are designated as Pre-vitellogenic, Early-vitellogenic, and Late-vitellogenic, respectively, and the eyestalk ganglion of males at stage III of AG development is designated as Stage III-AG. The data are presented as mean ± SEM (*n* = 6) with different letters indicating statistical significance at *p* \< 0.05.](fendo-11-00163-g0001){#F1}

5′-Flanking Sequence of *Sp-CFSH*
---------------------------------

A total of 1,250-bp 5′-flanking regions (GenBank accession number: [MN938502](MN938502)) were obtained from the transcriptional start site (TSS). The core promoter was located between −40 bp and +10 bp and contained the TSS and a TATA box (21 bp upstream of the TSS). Forecast analysis identified some transcription factor binding sites, such as Sp1, GATA-1, Wt1, Sox-2, C/EBPalp, and c-Jun ([Figure 2](#F2){ref-type="fig"}). One CpG island was found at −687 to −918 bp and contained 12 CpG sites ([Figure 3](#F3){ref-type="fig"}), in which CpG-1 and CpG-2 were located in the binding site of the transcription factor Sp1.

![The 5′-flanking region and putative *cis*-acting elements. The deduced transcriptional start site (**A**) is marked by red and defined as position 1. The nucleotide sequence is numbered on the left. The TATA box is marked in bold with red border. The putative transcription factor binding sites are marked by underlined, bold, or italic. Red arrows mark the beginning and end of CpG island, CpG-1 and CpG-2 are marked in red oval.](fendo-11-00163-g0002){#F2}

![The CpG island in the 5′-flanking sequence of *Sp-CFSH*. **(A)** CpG island predicted by MethPrimer (Island size \> 100, GC Percent \> 50.0, Obs/Exp \> 0.6). **(B)** The sequence of CpG island. Twelve CpG dinucleotides are marked with "+," and primers used for determination of DNA methylation are marked with "\>." CpG-1 and CpG-2 are marked in red oval.](fendo-11-00163-g0003){#F3}

*Sp-CFSH* Promoter Activity
---------------------------

The pEGFP-N1 contains the promoter of cytomegalovirus (CMV), as a positive control, which can effectively turn on the expression of EGFP and show a strong fluorescence ([Figure 4A](#F4){ref-type="fig"}). [Figure 4B](#F4){ref-type="fig"} showed the HEK293FT cells transfected with pEGFP-pCFSH, and the green cells demonstrated the promoter activity of the 5′-flanking sequence. The HEK293FT cells transfected with pEGFP-1 served as the negative control, and no fluorescence was detected ([Figure 4C](#F4){ref-type="fig"}).

![The expression of green fluorescence (EGFP) in HEK293FT cells. EGFP was detected in HEK293FT cells transfected with pEGFP-N1 **(A)**, pEGFP-pCFSH **(B)**, and pEGFP-1 **(C)**. pEGFP-N1 and pEGFP-1 were used as positive control and negative control, respectively.](fendo-11-00163-g0004){#F4}

CpG Island Methylation
----------------------

CpG island is known as the main target of methylation. In order to detect whether methylation is involved in the regulation of *Sp-CFSH* expression, sodium bisulfite sequencing was used to analyze the CpG island. The results showed that the level of CpG island methylation was similar in females at the stage between early-vitellogenic and late-vitellogenic, suggesting that CpG island methylation may be not involved in the regulation of *Sp-CFSH* expression during ovarian development. Compared with the eyestalk ganglion in females, CpG island methylation was significantly higher in the muscle of females and the eyestalk ganglion of males, suggesting that CpG island methylation may be involved in inhibiting *Sp-CFSH* expression in tissue-specific and gender-variant manners. The ratio of methylated CpG island in the eyestalk ganglion of females at the early-vitellogenic stage, late-vitellogenic stage, and muscle of females at the early-vitellogenic stage, as well as the eyestalk ganglion of males at the mature stage were 8.76, 8.85, 20.5, and 16.39% ([Figures 5A,C,E](#F5){ref-type="fig"}), respectively, and the methylation levels of the methylated CpG island was 22.22, 24.99, 45.46, and 41.67% ([Figures 5B,D,F](#F5){ref-type="fig"}), respectively.

![Methylation of CpG island. The percentage of methylated CpG island in the eyestalk ganglion of females at early-vitellogenic stage compared with the eyestalk ganglion at late-vitellogenic stage **(A)**, the muscle of females **(C)**, and the eyestalk ganglion of males **(E)**. The average methylation of CpG island between the eyestalk ganglion of females at early-vitellogenic stage and the eyestalk ganglion at late-vitellogenic stage **(B)**, the muscle of females **(D)**, the eyestalk ganglion of males **(F)**. Different letters represent significant difference between groups (*p* \< 0.05, one-way ANOVA followed by the Tukey\'s *post hoc* test). Each bar represents the mean ± SEM (*n* = 3).](fendo-11-00163-g0005){#F5}

MeDIP was carried out to further examine the effect of methylation on *Sp-CFSH* expression. While PCR of immunoprecipitated DNA fragments using normal IgG showed no amplified band, the immunoprecipitated DNA fragments using anti-5mC antibody were detected and showed that the amplified bands were more obvious in the muscle of females and the eyestalk ganglion of males than that in the eyestalk ganglion of females; in addition, the amplified bands of the DNA fragments were similar in three tissues ([Figure 6](#F6){ref-type="fig"}). MeDIP further demonstrated that CpG island methylation was significantly higher in the muscle of females and the eyestalk ganglion of males than that in the eyestalk ganglion of females, suggesting that CpG island methylation may be involved in inhibiting *Sp-CFSH* expression in tissue-specific and gender-variant manners.

![MeDIP results of CpG island methylation. Normal IgG, the immunoprecipitated DNA fragments using normal IgG; Anti-5mC antibody, the immunoprecipitated DNA fragments using anti-5mC antibody; Input, the DNA fragments. Normal IgG and Input were used as control. PCR amplified using primer sets corresponding to CpG island. Products were separated on 2.0% agarose gels and visualized by staining with GelRed. Early-vitellogenic, the eyestalk ganglion of females at early-vitellogenic stage; Stage III--AG, the eyestalk ganglion of males at stage III of AG development; Muscle, the muscle of females at early-vitellogenic stage.](fendo-11-00163-g0006){#F6}

Methylation of CpG Dinucleotide Sites
-------------------------------------

The methylation of CpG dinucleotide sites was further studied to explore their regulation of *Sp-CFSH* expression in tissue-specific and gender-variant manners. The results showed that, compared with the eyestalk ganglion of females, there are seven CpG sites with high methylation in the muscle of females, including CpG-1, CpG-2, CpG-3, CpG-5, CpG-6, CpG-10, and CpG-12 ([Figure 7A](#F7){ref-type="fig"}), and six CpG sites were found in the eyestalk ganglion of males with high methylation, including CpG-1, CpG-2, CpG-4, CpG-8, CpG-10, and CpG-12 ([Figure 7B](#F7){ref-type="fig"}). Among them, CpG-1, CpG-2, CpG-10, and CpG-12 were shared between a tissue-specific manner and a gender-variant manner, suggesting that they may play an equally important role in inhibiting *Sp-CFSH* expression in two manners. Moreover, combined with the analysis of the 5′-flanking sequence of *Sp-CFSH*, CpG-1 and CpG-2 were found to be located in the binding site of the transcription factor Sp1.

![Methylation of CpG dinucleotides sites. **(A)** Comparison of the methylation of CpG dinucleotides sites in the eyestalk ganglion between females and males. **(B)** Comparison of the methylation of CpG dinucleotide sites between the eyestalk ganglion and the muscle in females. Early-vitellogenic, the eyestalk ganglion of females at early-vitellogenic stage; Stage III--AG, the eyestalk ganglion of males at stage III of AG development; Muscle, the muscle of females at early-vitellogenic stage. Different letters represent significant difference between groups (*p* \< 0.05, one-way ANOVA followed by the Tukey\'s *post hoc* test). Each bar represents the mean ± SEM (*n* = 3).](fendo-11-00163-g0007){#F7}

Analysis of the Binding of Sp1 With the Site-Directed Mutation (SDM)
--------------------------------------------------------------------

SDM was performed to investigate whether methylation of CpG-1 and CpG-2 inhibits *Sp-CFSH* expression by blocking the binding of transcription factor Sp1. The reporter vectors were named as p*sp-cfsh* (ACTCGGCCGCGCTGG) and p*sp-cfsh*-M (ACTCTACCGCGCTGG), respectively ([Figure 8A](#F8){ref-type="fig"}), and results showed that the promoter activity of ps*p-cfsh-*M was significantly decreased (*p* \< 0.05) compared with that of ps*p-cfsh* ([Figure 8B](#F8){ref-type="fig"}), but both of them were significantly higher than that of the negative control (pGL3-basic).

![Analysis of the binding site of transcription factor Sp1 with SDM. **(A)** Schematic diagram of reporter vector; p*sp-cfsh*-M was constructed by mutating the binding site of Sp1 from p*sp-cfsh*. **(B)** The analysis of relative luciferase activity; pGL3-basic was served as the negative control. The data are presented as mean ± SEM (*n* = 3) with diverse letters indicating significant differences at *p* \< 0.05.](fendo-11-00163-g0008){#F8}

Discussion {#s4}
==========

To date, there are few reports on the epigenetic regulatory mechanism in crustaceans. In this study, DNA methylation was shown to be involved in inhibiting *Sp-CFSH* expression in an eyestalk ganglion-specific and gender-variant pattern in the mud crab *S. paramamosain*.

To explore the regulatory mechanism of *Sp-CFSH* expression, the 5′-flanking region of *Sp-CFSH* was cloned and analyzed in this study. A total of 1,250-bp 5′-flanking regions were obtained and contained the core promoter with a TATA box, which is consistent with previous studies that there is only one transcription initiation site and a TATA box in the promoter ([@B36], [@B37]). Forecast analysis found some regulatory factor binding sites in the 5′-flanking regions of *Sp-CFSH*, such as GATA-1, Wt1, Sox-2, TBP, Sp1, C/EBPalp, and c-Jun. As we know, the eukaryotic promoter modulates the gene expression by the response to regulatory factor ([@B8], [@B9]).

In the present study, one CpG island was found in the 5′-flanking regions of *Sp-CFSH*, including 12 CpG sites, the presence of which suggests that *Sp-CFSH* expression may be regulated by DNA methylation. CpG island, as the major target for methylation, plays an important role in epigenetic regulation of gene expression ([@B16]). Most researches on DNA methylation has been done in vertebrates and plants, generally demonstrating that DNA methylation is involved in the silencing of gene expression ([@B11]--[@B15]). A study on DNA methylation in *S. paramamosain*, an important economic species of aquaculture, is completely lacking. In this study, CpG island methylation was analyzed, and the results showed that CpG island methylation was significantly higher in the muscle of females and the eyestalk ganglion of males compared to that in the eyestalk ganglion of females ([Figures 5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}), and that was inversely correlated with the *Sp-CFSH* expression ([@B27]), suggesting that methylation may be involved in inhibiting *Sp-CFSH* expression in tissue-specific and gender-variant manners by reducing the activity of the promoter ([@B38]).

The methylation of CpG dinucleotide sites including CpG-1, CpG-2, CpG-4, CpG-8, CpG-10, and CpG-12 in the eyestalk ganglion of males and CpG-1, CpG-2, CpG-3, CpG-5, CpG-6, CpG-10, and CpG-12 in the muscle of females was significantly higher than that of the eyestalk ganglion of females, suggesting that they could play a vital role in the regulation of *Sp-CFSH* expression in gender-variant and tissue-specific manners, respectively. Moreover, CpG-1, CpG-2, CpG-10, and CpG-12 have high methylation in the muscle of females and the eyestalk ganglion of males, suggesting that they may play an equally important role in the regulation of *Sp-CFSH* expression in tissue-specific and gender-variant manners. CpG-1 and CpG-2 were found to be located in the binding site of transcription factor Sp1. In addition, our results of the activity analysis of the SDM reporter vector showed that SP1, as the transcriptional activator, plays a crucial role in promoter activity. Sp1 is a vital component of the eukaryotic cellular transcriptional machinery, which fine tunes cellular functions by regulating the gene expression with GC-rich promoters. Previous studies showed that DNA methylation interferes with the binding of Sp1 to *cis* sites ([@B39]--[@B43]). In the retinoblastoma gene, methylation of the CpG island directly inhibits the binding of Sp1 ([@B44]). In extracellular superoxide dismutase (EC-SOD) gene, methylation markedly decreased Sp1-/Sp3-driven promoter activity and was, at least in part, attributable to the competition of the methyl-binding protein MeCP2 with Sp1 for the same binding sites ([@B45]). Moreover, in the Synapsin I (SYN1) gene, methylation of Sp1 *cis* sites assist RE1-silencing transcription factor (REST) in the inhibition of SYN1 transcription ([@B46]). For these reasons, it was speculated that methylation of CpG-1 and CpG-2 may be involved in inhibition of Sp1 binding or the effectiveness of repressor complex, therefore leading to a reduced *Sp-CFSH* expression in tissue-specific and gender-variant manners.

In the present study, the difference between 22.22 and 45.46%/41.67% methylation levels of CpG island ([Figure 5](#F5){ref-type="fig"}), and the difference of 1.5--7.05% vs. 8.25--14.25% methylation levels of CpG dinucleotide sites ([Figure 7](#F7){ref-type="fig"}) have the significant consequence in *Sp-CFSH* expression, suggesting that *Sp-CFSH* expression was sensitive to slight methylation. It has been reported that the effect of methylation on gene expression depended on several parameters, including the location of CpG dinucleotide relative to the promoter ([@B47]), the local density of methylated CpG dinucleotide ([@B48]), the strength of the promoter ([@B48]), and the dependence of promoter function on transcription factors that are sensitive to methylated CpG dinucleotide ([@B49]). In this study, methylated CpG-1 and CpG-2 were located in the binding site of transcription factor Sp1, suggesting that Sp1 may contribute to the *Sp-CFSH* expression. Previous studies have already verified that subtle changes in methylation status can induce remarkable impacts at the organismal level. For example, methylation patterns can be modulated by environmental conditions in the California mussel, *Mytilus californianus*, and the change in methylation status of LIG4 gene can be largely attributed to a single CpG site ([@B50]).

The mud crab, *S. paramamosain*, is an annual animal and reproduces once in its lifetime. The ovarian development goes through three main stages: pre-vitellogenic stage, early-vitellogenic stage, and late-vitellogenic stage ([@B30], [@B31]). In this study, *Sp-CFSH* expression was also found to be different in females during ovarian development. This is not the only finding that shows that *Sp-CFSH* expression is linked to ovarian development. In kuruma prawn, *Marsupenaeus japonicus*, a CFSH isoform was also found to be highly expressed in the ovary and localized to oogonia and pre-vitellogenic oocytes in vitellogenic ovaries ([@B51]). Therefore, it is speculated that *Sp-CFSH* may also be involved in the regulation of ovarian development, especially in the stimulation of oocyte vitellogenesis. To exclude the influence of environment factors on methylation, female crabs from the same sea area and season were selected in this study. Although *Sp-CFSH* expression changed remarkably during ovarian development, CpG island methylation remained stable in the eyestalk ganglion. It showed that methylation was not involved in the regulation of *Sp-CFSH* expression during ovarian development. In addition to epigenetic regulation, the synthesis and release of neurohormone can also be regulated by some neurotransmitters in crustaceans ([@B52]--[@B56]), such as serotonin (5-hydroxytryptamine, 5-HT). It has been reported that 5-HT stimulates the release of neurohormones, including the crustacean hyperglycemic hormone, red pigment-dispersing hormone, neurodepressing hormone, molt-inhibiting hormone, and red pigment-concentrating hormone in the red swamp crayfish, *Procambarus clarkii* ([@B57]--[@B59]) and the white Pacific shrimp, *Litopenaeus vannamei* ([@B60]). Recent studies also demonstrate that 5-HT can promote ovarian *MroCFSHs* expression in the giant freshwater prawn, *Macrobrachium rosenbergii* ([@B61]). Therefore, the fluctuation *Sp-CFSH* expression during ovarian development may be influenced by other endocrine regulators, such as 5-HT. In addition, post-transcriptional regulation is another important way to affect the fate of mRNA, which can be realized by various modifications of mRNA to meet the needs of different physiological states ([@B62]). The regulatory mechanism of *Sp-CFSH* expression remains to be further explored.

In summary, the 5′-flanking region of *Sp-CFSH* was first cloned and analyzed in this study. Analysis of CpG island methylation proved that DNA methylation was involved in inhibiting *Sp-CFSH* expression in eyestalk ganglion-specific and gender-variant pattern in *S. paramamosain*. Analysis of CpG dinucleotide site methylation and activity of SDM reporter vector demonstrated that methylation inhibited *Sp-CFSH* expression by blocking the binding of transcription factor Sp1. The finding suggested, for the first time, the involvement of CpG methylation in the regulation of *Sp-CFSH* expression.
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Hematoxylin and eosin (HE) staining in ovaries. **(A)** pre-vitellogenic ovaries, **(B)** early-vitellogenic ovaries, **(C)** late-vitellogenic ovaries. Og, oogonia; Oc, oocyte; FC, follicle cell; n, nucleus; nu, nucleolus; yg, yolk granules.
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